Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Entropic Biosciences is a life sciences company specializing in the isolation and analysis of extracellular vesicles (EVs) and other biological nanoparticles. The company utilizes its proprietary "Entropic Trapping" technology, a passive, size-based separation method that enables high-purity and high-yield recovery of EVs from complex biofluids without the need for specialized equipment or harsh chemicals. By simplifying the workflow for liquid biopsies and biomarker discovery, Entropic aims to accelerate the development of EV-based diagnostics and therapeutics. Their platform is designed to be scalable and compatible with standard laboratory infrastructure, addressing a major bottleneck in the field of exosome research. The company provides both research-use kits and diagnostic development services to pharmaceutical and academic partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Entropic.